Changsha, China

Qianjin Lu

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qianjin Lu: Innovator in Inflammatory Skin Disease Treatment

Introduction

Qianjin Lu is a prominent inventor based in Changsha, China. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory skin diseases. His innovative approach has led to the development of a unique therapeutic strategy that addresses the underlying mechanisms of these conditions.

Latest Patents

Qianjin Lu holds a patent titled "Application of microRNA-210 inhibitor in preparation of drugs for treating inflammatory skin diseases." This patent discloses methods for utilizing a microRNA-210 inhibitor to prepare drugs aimed at treating inflammatory skin diseases. Through extensive experimentation, he has demonstrated that inhibiting microRNA-210 expression can significantly enhance the expression of its target gene, STAT6. This process inhibits the proliferation and chemokine CCL20 secretion of keratinocytes, thereby reducing T cell migration towards skin lesions and inhibiting the differentiation of T1 and T17 cells. His research indicates that microRNA-210 knockout and intradermal injection of a microRNA-210 inhibitor can significantly mitigate skin inflammation in mice, providing a new pathophysiological mechanism and strategy for drug preparation in treating inflammatory skin diseases. Qianjin Lu has 1 patent to his name.

Career Highlights

Throughout his career, Qianjin Lu has worked at notable institutions, including the Second Xiangya Hospital of Central South University and the University of Michigan. His work in these esteemed organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Qianjin Lu has collaborated with several notable individuals, including Ming Zhao and Yuwen Su. These partnerships have further enhanced his research and innovation in the medical field.

Conclusion

Qianjin Lu's innovative work in the treatment of inflammatory skin diseases showcases his dedication to advancing medical science. His patent on the application of microRNA-210 inhibitors represents a significant step forward in therapeutic strategies for these conditions. His contributions continue to inspire future research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…